Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Kivu Bioscience Inc.
Hoffmann-La Roche
Aveni Foundation
Bayer
University of California, Irvine
ViroMissile, Inc.
Dana-Farber Cancer Institute
Kaiser Permanente
Children's Oncology Group
AstraZeneca
University of Florida
Essen Biotech
MacroGenics
Avacta Life Sciences Ltd
Institut Curie
Solve Therapeutics
University of Nebraska
Adela, Inc
Perspective Therapeutics
Ocellaris Pharma, Inc.
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Tanabe Pharma America, Inc.
University Health Network, Toronto
University of Southern California
Blueprint Medicines Corporation
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Actym Therapeutics, Inc.
M.D. Anderson Cancer Center
Hadassah Medical Organization
AVM Biotechnology Inc
City of Hope Medical Center
Travera Inc
Institut Bergonié
Washington University School of Medicine
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
Leap Therapeutics, Inc.
Incyte Corporation
Leap Therapeutics, Inc.
Numab Therapeutics AG
Institut Bergonié
University of California, Irvine
Gradalis, Inc.
Baxter Healthcare Corporation
Tempus AI